4//SEC Filing
Silberman David 4
Accession 0001209191-23-024936
CIK 0001176309other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 6:00 AM ET
Size
5.0 KB
Accession
0001209191-23-024936
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2023-04-17+97,500→ 205,500 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 8,125 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001867998
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 6:00 AM ET
- Size
- 5.0 KB